Charles Schwab Investment Management Inc Rezolute, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,757 shares of RZLT stock, worth $59,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,757
Previous 13,757
-0.0%
Holding current value
$59,155
Previous $13,000
169.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
33Shares Held
26.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$43.7 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.02MShares$13 Million0.5% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$12 Million0.95% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.6MShares$6.88 Million0.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$6.68 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $167M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...